Alberto J Pacheco

About Alberto J Pacheco

I am a strategic and results-driven pharmaceutical and biotech leader with two decades of experience leading inspection readiness activities focused on sponsor oversight of clinical operations across high-impact therapeutic areas, including oncology, rare diseases, cell and gene therapy, vaccines, respiratory, CNS, and medical devices.Atop a dependable GxP compliance and clinical operations foundation, I bring a unique ability to align operational execution with corporate vision, driving cross-functional optimization, risk mitigation, and process innovation. I have built a reputation for transforming complexity into clarity, developing methods to prioritize and quantify risk, and enhancing Trial Oversight models to enable consistency, efficiency, and global regulatory readiness across critical asset portfolios. I am keenly aware of trends and the types of challenges faced by sponsor companies, having led numerous initiatives to assess inspection risks for critical assets and developing comprehensive mitigation plans.I lead from the front by navigating the ever-evolving regulatory landscape to drive cross-functional inspection readiness initiatives at forward-thinking biotech and pharma companies. The direct effect is a continual improvement loop rooted in Quality by Design and Risk Management principles, that accelerates clinical development timelines by proactively embedding quality at every stage of the product lifecycle. And in this pursuit, I am passionate about building and developing collaborative, high-performing teams that deliver results, and ultimately, hope to patients.Let’s connect!

Experience

1. Director of Quality Assurance

   Revolution Medicines

   Feb 2026 — Present

Education

• The Johns Hopkins University

  BA, Behavioral Biology

  1999 — 2003